Search Results - Nazanin Tatari
- Showing 1 - 3 results of 3
-
1
Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors by Nazanin Tatari, Nazanin Tatari, Xiaoyu Zhang, Xiaoyu Zhang, Shawn C. Chafe, Shawn C. Chafe, Dillon McKenna, Dillon McKenna, Keith A. Lawson, Keith A. Lawson, Minomi Subapanditha, Minomi Subapanditha, Muhammad Vaseem Shaikh, Muhammad Vaseem Shaikh, Mathieu Seyfrid, Mathieu Seyfrid, Neil Savage, Neil Savage, Chitra Venugopal, Chitra Venugopal, Jason Moffat, Jason Moffat, Sheila K. Singh, Sheila K. Singh, Sheila K. Singh
Published in Frontiers in Immunology (2022-07-01)Get full text
Article -
2
FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma by Michal Beffinger, Linda Schellhammer, Betül Taskoparan, Sereina Deplazes, Ulisse Salazar, Nazanin Tatari, Frauke Seehusen, Leopold von Balthazar, Carl Philipp Zinner, Sabine Spath, Tala Shekarian, Marie-Françoise Ritz, Marta McDaid, Pascal Egloff, Iwan Zimmermann, Hideho Okada, E. Sally Ward, Jack Rohrer, Markus A. Seeger, Thorsten Buch, Gregor Hutter, Johannes vom Berg
Published in Nature Communications (2025-05-01)Get full text
Article -
3
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker by Tomás A. Martins, Deniz Kaymak, Nazanin Tatari, Fiona Gerster, Sabrina Hogan, Marie-Françoise Ritz, Valerio Sabatino, Ronja Wieboldt, Ewelina M. Bartoszek, Marta McDaid, Alexandra Gerber, Alicia Buck, Aisha Beshirova, Anja Heider, Tala Shekarian, Hayget Mohamed, Manina M. Etter, Philip Schmassmann, Ines Abel, Jean-Louis Boulay, Yasuyuki Saito, Luigi Mariani, Raphael Guzman, Berend Snijder, Tobias Weiss, Heinz Läubli, Gregor Hutter
Published in Nature Communications (2024-11-01)Get full text
Article
